Kathmere Capital Management, LLC Edwards Lifesciences Corp Transaction History

Kathmere Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$86.5 - $128.27 $15,743 - $23,345	182 Added 6.15%	3,139 $298,000
Q1 2022 Apr 28, 2022	BUY	$101.96 - $128.34 $301,495 - $379,501	2,957 New	2,957 $348,000
Q4 2021 Jan 27, 2022	SELL	$106.37 - $130.68 $317,939 - $390,602	-2,989 Closed	0 $0
Q3 2021 Oct 14, 2021	BUY	$102.91 - $122.75 $11,217 - $13,379	109 Added 3.78%	2,989 $338,000
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $2,150 - $2,736	30 Added 1.05%	2,880 $263,000
Q3 2020 Nov 20, 2020	BUY	$67.19 - $87.44 $191,491 - $249,204	2,850 New	2,850 $227,000
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $325,333 - $423,384	-4,842 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$57.54 - $76.95 $278,608 - $372,591	4,842 New	4,842 $335,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kathmere Capital Management, LLC with notifications on news.